Newport Diagnostics — Newport Beach, California

Newport Diagnostics is a clinical research site located in Newport Beach, California, United States 92660.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Newport Diagnostics has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Urothelial Carcinoma.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Newport Diagnostics?

Newport Diagnostics has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Newport Diagnostics conducted?

Newport Diagnostics has 1 clinical trials on record, with 1 currently active. Their work covers Urothelial Carcinoma.

Is Newport Diagnostics accredited by Crixeo Health?

Newport Diagnostics has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Newport Diagnostics?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.